APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anti-allergic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Anti-allergic Drugs Market Analysis and Forecast 2026-2032

22 December 2025206 pages

Choose your research edition.

Industry ResearchOral Anti-allergic Drugs Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anti-allergic Drugs Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Oral Anti-allergic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anti-allergic Drugs Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anti-allergic Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Oral Anti-allergic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Anti-allergic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Anti-allergic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Anti-allergic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Anti-allergic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Anti-allergic Drugs include Chongqing Huapont Pharmaceutical, Yangtze River Pharmaceutical Group, Teva, Sun Pharma, Sanofi, Johnson & Johnson, Hainan Poly Pharm, Novartis and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Anti-allergic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Anti-allergic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Anti-allergic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Anti-allergic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Anti-allergic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Anti-allergic Drugs sales, projected growth trends, production technology, application and end-user industry.

Oral Anti-allergic Drugs Segment by Company

Chongqing Huapont Pharmaceutical

Yangtze River Pharmaceutical Group

Teva

Sun Pharma

Sanofi

Johnson & Johnson

Hainan Poly Pharm

Novartis

Merck

Pfizer

GlaxoSmithKline

Dawnrays Pharma

Bayer

AstraZeneca

UCB Pharma

Boehringer Ingelheim

Almirall

Oral Anti-allergic Drugs Segment by Type

Immunosuppressant Drugs

Antihistamine Drugs

Allergic Mediator Release Agent

Oral Anti-allergic Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Oral Anti-allergic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anti-allergic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anti-allergic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anti-allergic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Anti-allergic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Anti-allergic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Anti-allergic Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immunosuppressant Drugs Major Manufacturers Table 3. Antihistamine Drugs Major Manufacturers Table 4. Allergic Mediator Release Agent Major Manufacturers Table 5. Global Oral Anti-allergic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Manufacturers Table 7. Online Pharmacies Major Manufacturers Table 8. Retail Pharmacies Major Manufacturers Table 9. Oral Anti-allergic Drugs Industry Trends Table 10. Oral Anti-allergic Drugs Industry Drivers Table 11. Oral Anti-allergic Drugs Industry Opportunities and Challenges Table 12. Oral Anti-allergic Drugs Industry Restraints Table 13. Global Oral Anti-allergic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Oral Anti-allergic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Oral Anti-allergic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2021-2026) Table 17. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2027-2032) Table 18. Global Oral Anti-allergic Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Oral Anti-allergic Drugs Sales by Region (2021-2026) & (k units) Table 20. Global Oral Anti-allergic Drugs Sales by Region (2027-2032) & (k units) Table 21. Global Oral Anti-allergic Drugs Sales Market Share by Region (2021-2026) Table 22. Global Oral Anti-allergic Drugs Sales Market Share by Region (2027-2032) Table 23. Global Oral Anti-allergic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oral Anti-allergic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Oral Anti-allergic Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Oral Anti-allergic Drugs Sales Market Share by Manufacturers (2021-2026) Table 27. Global Oral Anti-allergic Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Oral Anti-allergic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Oral Anti-allergic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Oral Anti-allergic Drugs Manufacturers, Product Type & Application Table 31. Global Oral Anti-allergic Drugs Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Oral Anti-allergic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Oral Anti-allergic Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2021-2026) Table 38. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2027-2032) Table 39. Global Oral Anti-allergic Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 41. Global Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 42. Global Oral Anti-allergic Drugs Sales Market Share by Type (2021-2026) Table 43. Global Oral Anti-allergic Drugs Sales Market Share by Type (2027-2032) Table 44. Global Oral Anti-allergic Drugs Price by Type (2021-2026) & (US$/unit) Table 45. Global Oral Anti-allergic Drugs Price by Type (2027-2032) & (US$/unit) Table 46. Global Oral Anti-allergic Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2021-2026) Table 50. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2027-2032) Table 51. Global Oral Anti-allergic Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 53. Global Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 54. Global Oral Anti-allergic Drugs Sales Market Share by Application (2021-2026) Table 55. Global Oral Anti-allergic Drugs Sales Market Share by Application (2027-2032) Table 56. Global Oral Anti-allergic Drugs Price by Application (2021-2026) & (US$/unit) Table 57. Global Oral Anti-allergic Drugs Price by Application (2027-2032) & (US$/unit) Table 58. Chongqing Huapont Pharmaceutical Company Information Table 59. Chongqing Huapont Pharmaceutical Business Overview Table 60. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Portfolio Table 62. Chongqing Huapont Pharmaceutical Recent Development Table 63. Yangtze River Pharmaceutical Group Company Information Table 64. Yangtze River Pharmaceutical Group Business Overview Table 65. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Portfolio Table 67. Yangtze River Pharmaceutical Group Recent Development Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Teva Oral Anti-allergic Drugs Product Portfolio Table 72. Teva Recent Development Table 73. Sun Pharma Company Information Table 74. Sun Pharma Business Overview Table 75. Sun Pharma Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sun Pharma Oral Anti-allergic Drugs Product Portfolio Table 77. Sun Pharma Recent Development Table 78. Sanofi Company Information Table 79. Sanofi Business Overview Table 80. Sanofi Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sanofi Oral Anti-allergic Drugs Product Portfolio Table 82. Sanofi Recent Development Table 83. Johnson & Johnson Company Information Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Johnson & Johnson Oral Anti-allergic Drugs Product Portfolio Table 87. Johnson & Johnson Recent Development Table 88. Hainan Poly Pharm Company Information Table 89. Hainan Poly Pharm Business Overview Table 90. Hainan Poly Pharm Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Hainan Poly Pharm Oral Anti-allergic Drugs Product Portfolio Table 92. Hainan Poly Pharm Recent Development Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Novartis Oral Anti-allergic Drugs Product Portfolio Table 97. Novartis Recent Development Table 98. Merck Company Information Table 99. Merck Business Overview Table 100. Merck Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Merck Oral Anti-allergic Drugs Product Portfolio Table 102. Merck Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Pfizer Oral Anti-allergic Drugs Product Portfolio Table 107. Pfizer Recent Development Table 108. GlaxoSmithKline Company Information Table 109. GlaxoSmithKline Business Overview Table 110. GlaxoSmithKline Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. GlaxoSmithKline Oral Anti-allergic Drugs Product Portfolio Table 112. GlaxoSmithKline Recent Development Table 113. Dawnrays Pharma Company Information Table 114. Dawnrays Pharma Business Overview Table 115. Dawnrays Pharma Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Dawnrays Pharma Oral Anti-allergic Drugs Product Portfolio Table 117. Dawnrays Pharma Recent Development Table 118. Bayer Company Information Table 119. Bayer Business Overview Table 120. Bayer Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Bayer Oral Anti-allergic Drugs Product Portfolio Table 122. Bayer Recent Development Table 123. AstraZeneca Company Information Table 124. AstraZeneca Business Overview Table 125. AstraZeneca Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. AstraZeneca Oral Anti-allergic Drugs Product Portfolio Table 127. AstraZeneca Recent Development Table 128. UCB Pharma Company Information Table 129. UCB Pharma Business Overview Table 130. UCB Pharma Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. UCB Pharma Oral Anti-allergic Drugs Product Portfolio Table 132. UCB Pharma Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Oral Anti-allergic Drugs Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. Almirall Company Information Table 139. Almirall Business Overview Table 140. Almirall Oral Anti-allergic Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Almirall Oral Anti-allergic Drugs Product Portfolio Table 142. Almirall Recent Development Table 143. North America Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 146. North America Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 147. North America Oral Anti-allergic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 148. North America Oral Anti-allergic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 149. North America Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 150. North America Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 151. North America Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 152. North America Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 153. North America Oral Anti-allergic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 154. North America Oral Anti-allergic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 155. North America Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. North America Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 157. North America Oral Anti-allergic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 158. North America Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 159. North America Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 160. North America Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 161. North America Oral Anti-allergic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 162. North America Oral Anti-allergic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 163. United States Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 164. Canada Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 165. Mexico Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 166. Europe Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 169. Europe Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 170. Europe Oral Anti-allergic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 171. Europe Oral Anti-allergic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 172. Europe Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 175. Europe Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 176. Europe Oral Anti-allergic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 177. Europe Oral Anti-allergic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 178. Europe Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Oral Anti-allergic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Europe Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 183. Europe Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 184. Europe Oral Anti-allergic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 185. Europe Oral Anti-allergic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 186. Germany Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 187. France Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 188. U.K. Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 189. Italy Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 190. Russia Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 191. Spain Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 192. Netherlands Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 193. Switzerland Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 194. Sweden Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 195. Poland Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 196. China Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 197. China Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 198. China Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 199. China Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 200. China Oral Anti-allergic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 201. China Oral Anti-allergic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 202. China Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 203. China Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 204. China Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 205. China Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 206. China Oral Anti-allergic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 207. China Oral Anti-allergic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 208. Asia Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 211. Asia Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 212. Asia Oral Anti-allergic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 213. Asia Oral Anti-allergic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 214. Asia Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 215. Asia Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 216. Asia Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 217. Asia Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 218. Asia Oral Anti-allergic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 219. Asia Oral Anti-allergic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 220. Asia Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. Asia Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. Asia Oral Anti-allergic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. Asia Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 224. Asia Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 225. Asia Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 226. Asia Oral Anti-allergic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 227. Asia Oral Anti-allergic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 228. Japan Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 229. South Korea Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 230. India Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 231. Australia Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 232. Taiwan Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 233. Southeast Asia Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 234. SAMEA Oral Anti-allergic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 235. SAMEA Oral Anti-allergic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 236. SAMEA Oral Anti-allergic Drugs Sales by Type (2021-2026) & (k units) Table 237. SAMEA Oral Anti-allergic Drugs Sales by Type (2027-2032) & (k units) Table 238. SAMEA Oral Anti-allergic Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 239. SAMEA Oral Anti-allergic Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 240. SAMEA Oral Anti-allergic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 241. SAMEA Oral Anti-allergic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 242. SAMEA Oral Anti-allergic Drugs Sales by Application (2021-2026) & (k units) Table 243. SAMEA Oral Anti-allergic Drugs Sales by Application (2027-2032) & (k units) Table 244. SAMEA Oral Anti-allergic Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 245. SAMEA Oral Anti-allergic Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 246. SAMEA Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. SAMEA Oral Anti-allergic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. SAMEA Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 250. SAMEA Oral Anti-allergic Drugs Sales by Country (2021-2026) & (k units) Table 251. SAMEA Oral Anti-allergic Drugs Sales by Country (2027-2032) & (k units) Table 252. SAMEA Oral Anti-allergic Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 253. SAMEA Oral Anti-allergic Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 254. Brazil Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 255. Argentina Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 256. Chile Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 257. Colombia Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 258. Peru Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 259. Saudi Arabia Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 260. Israel Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 261. UAE Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 262. Turkey Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 263. Iran Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 264. Egypt Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Table 265. Key Raw Materials Table 266. Raw Materials Key Suppliers Table 267. Oral Anti-allergic Drugs Distributors List Table 268. Oral Anti-allergic Drugs Customers List Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Oral Anti-allergic Drugs Image Figure 2. Global Oral Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anti-allergic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immunosuppressant Drugs Image Figure 5. Antihistamine Drugs Image Figure 6. Allergic Mediator Release Agent Image Figure 7. Global Oral Anti-allergic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Oral Anti-allergic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global Oral Anti-allergic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Oral Anti-allergic Drugs Revenue (2021-2032) & (US$ Million) Figure 14. Global Oral Anti-allergic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Oral Anti-allergic Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Oral Anti-allergic Drugs Revenue Market Share by Region (2021-2032) Figure 17. Global Oral Anti-allergic Drugs Sales (2021-2032) & (k units) Figure 18. Global Oral Anti-allergic Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Oral Anti-allergic Drugs Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Oral Anti-allergic Drugs Sales YoY (2021-2032) & (k units) Figure 21. Europe Oral Anti-allergic Drugs Sales YoY (2021-2032) & (k units) Figure 22. China Oral Anti-allergic Drugs Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Oral Anti-allergic Drugs Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Oral Anti-allergic Drugs Sales YoY (2021-2032) & (k units) Figure 25. Global Oral Anti-allergic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Oral Anti-allergic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Oral Anti-allergic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Oral Anti-allergic Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Oral Anti-allergic Drugs Revenue Market Share by Type (2021-2032) Figure 31. Global Oral Anti-allergic Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Oral Anti-allergic Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Oral Anti-allergic Drugs Sales Market Share by Type (2021-2032) Figure 34. Global Oral Anti-allergic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Oral Anti-allergic Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Oral Anti-allergic Drugs Revenue Market Share by Application (2021-2032) Figure 37. Global Oral Anti-allergic Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Oral Anti-allergic Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Oral Anti-allergic Drugs Sales Market Share by Application (2021-2032) Figure 40. North America Oral Anti-allergic Drugs Revenue Share by Type (2021-2032) Figure 41. North America Oral Anti-allergic Drugs Sales Share by Type (2021-2032) Figure 42. North America Oral Anti-allergic Drugs Revenue Share by Application (2021-2032) Figure 43. North America Oral Anti-allergic Drugs Sales Share by Application (2021-2032) Figure 44. North America Oral Anti-allergic Drugs Revenue Share by Country (2021-2032) Figure 45. North America Oral Anti-allergic Drugs Sales Share by Country (2021-2032) Figure 46. Europe Oral Anti-allergic Drugs Revenue Share by Type (2021-2032) Figure 47. Europe Oral Anti-allergic Drugs Sales Share by Type (2021-2032) Figure 48. Europe Oral Anti-allergic Drugs Revenue Share by Application (2021-2032) Figure 49. Europe Oral Anti-allergic Drugs Sales Share by Application (2021-2032) Figure 50. Europe Oral Anti-allergic Drugs Revenue Share by Country (2021-2032) Figure 51. Europe Oral Anti-allergic Drugs Sales Share by Country (2021-2032) Figure 52. China Oral Anti-allergic Drugs Revenue Share by Type (2021-2032) Figure 53. China Oral Anti-allergic Drugs Sales Share by Type (2021-2032) Figure 54. China Oral Anti-allergic Drugs Revenue Share by Application (2021-2032) Figure 55. China Oral Anti-allergic Drugs Sales Share by Application (2021-2032) Figure 56. Asia Oral Anti-allergic Drugs Revenue Share by Type (2021-2032) Figure 57. Asia Oral Anti-allergic Drugs Sales Share by Type (2021-2032) Figure 58. Asia Oral Anti-allergic Drugs Revenue Share by Application (2021-2032) Figure 59. Asia Oral Anti-allergic Drugs Sales Share by Application (2021-2032) Figure 60. Asia Oral Anti-allergic Drugs Revenue Share by Country (2021-2032) Figure 61. Asia Oral Anti-allergic Drugs Sales Share by Country (2021-2032) Figure 62. SAMEA Oral Anti-allergic Drugs Revenue Share by Type (2021-2032) Figure 63. SAMEA Oral Anti-allergic Drugs Sales Share by Type (2021-2032) Figure 64. SAMEA Oral Anti-allergic Drugs Revenue Share by Application (2021-2032) Figure 65. SAMEA Oral Anti-allergic Drugs Sales Share by Application (2021-2032) Figure 66. SAMEA Oral Anti-allergic Drugs Revenue Share by Country (2021-2032) Figure 67. SAMEA Oral Anti-allergic Drugs Sales Share by Country (2021-2032) Figure 68. Oral Anti-allergic Drugs Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Oral Anti-allergic Drugs Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Immunosuppressant Drugs
  • Antihistamine Drugs
  • Allergic Mediator Release Agent
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Yangtze River Pharmaceutical Group
  • Teva
  • Sun Pharma
  • Sanofi
  • Johnson & Johnson
  • Hainan Poly Pharm
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Dawnrays Pharma
  • Bayer
  • AstraZeneca
  • UCB Pharma
  • Boehringer Ingelheim
  • Almirall

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Anti-allergic Drugs Market by Type
  3. 1.2.1 Global Oral Anti-allergic Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immunosuppressant Drugs
  5. 1.2.3 Antihistamine Drugs
  6. 1.2.4 Allergic Mediator Release Agent
  7. 1.3 Oral Anti-allergic Drugs Market by Application
  8. 1.3.1 Global Oral Anti-allergic Drugs Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Oral Anti-allergic Drugs Market Dynamics
  1. 2.1 Oral Anti-allergic Drugs Industry Trends
  2. 2.2 Oral Anti-allergic Drugs Industry Drivers
  3. 2.3 Oral Anti-allergic Drugs Industry Opportunities and Challenges
  4. 2.4 Oral Anti-allergic Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Anti-allergic Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Anti-allergic Drugs Revenue by Region
  3. 3.2.1 Global Oral Anti-allergic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Anti-allergic Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Anti-allergic Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Anti-allergic Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Anti-allergic Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Anti-allergic Drugs Sales by Region
  9. 3.4.1 Global Oral Anti-allergic Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Anti-allergic Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Anti-allergic Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Anti-allergic Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Anti-allergic Drugs Revenue by Manufacturers
  2. 4.1.1 Global Oral Anti-allergic Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Anti-allergic Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Anti-allergic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Anti-allergic Drugs Sales by Manufacturers
  6. 4.2.1 Global Oral Anti-allergic Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Anti-allergic Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Anti-allergic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Anti-allergic Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Anti-allergic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Anti-allergic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Anti-allergic Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Oral Anti-allergic Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Anti-allergic Drugs Market CR5 and HHI
  16. 4.8.2 2025 Oral Anti-allergic Drugs Tier 1, Tier 2, and Tier 3
5 Oral Anti-allergic Drugs Market by Type
  1. 5.1 Global Oral Anti-allergic Drugs Revenue by Type
  2. 5.1.1 Global Oral Anti-allergic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Anti-allergic Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Anti-allergic Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Anti-allergic Drugs Sales by Type
  6. 5.2.1 Global Oral Anti-allergic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Anti-allergic Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Oral Anti-allergic Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Anti-allergic Drugs Price by Type
6 Oral Anti-allergic Drugs Market by Application
  1. 6.1 Global Oral Anti-allergic Drugs Revenue by Application
  2. 6.1.1 Global Oral Anti-allergic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Anti-allergic Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Anti-allergic Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Anti-allergic Drugs Sales by Application
  6. 6.2.1 Global Oral Anti-allergic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Anti-allergic Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Oral Anti-allergic Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Anti-allergic Drugs Price by Application
7 Company Profiles
  1. 7.1 Chongqing Huapont Pharmaceutical
  2. 7.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 7.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 7.1.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Portfolio
  6. 7.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 7.2 Yangtze River Pharmaceutical Group
  8. 7.2.1 Yangtze River Pharmaceutical Group Company Information
  9. 7.2.2 Yangtze River Pharmaceutical Group Business Overview
  10. 7.2.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Portfolio
  12. 7.2.5 Yangtze River Pharmaceutical Group Recent Developments
  13. 7.3 Teva
  14. 7.3.1 Teva Company Information
  15. 7.3.2 Teva Business Overview
  16. 7.3.3 Teva Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Teva Oral Anti-allergic Drugs Product Portfolio
  18. 7.3.5 Teva Recent Developments
  19. 7.4 Sun Pharma
  20. 7.4.1 Sun Pharma Company Information
  21. 7.4.2 Sun Pharma Business Overview
  22. 7.4.3 Sun Pharma Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sun Pharma Oral Anti-allergic Drugs Product Portfolio
  24. 7.4.5 Sun Pharma Recent Developments
  25. 7.5 Sanofi
  26. 7.5.1 Sanofi Company Information
  27. 7.5.2 Sanofi Business Overview
  28. 7.5.3 Sanofi Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Oral Anti-allergic Drugs Product Portfolio
  30. 7.5.5 Sanofi Recent Developments
  31. 7.6 Johnson & Johnson
  32. 7.6.1 Johnson & Johnson Company Information
  33. 7.6.2 Johnson & Johnson Business Overview
  34. 7.6.3 Johnson & Johnson Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Johnson & Johnson Oral Anti-allergic Drugs Product Portfolio
  36. 7.6.5 Johnson & Johnson Recent Developments
  37. 7.7 Hainan Poly Pharm
  38. 7.7.1 Hainan Poly Pharm Company Information
  39. 7.7.2 Hainan Poly Pharm Business Overview
  40. 7.7.3 Hainan Poly Pharm Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hainan Poly Pharm Oral Anti-allergic Drugs Product Portfolio
  42. 7.7.5 Hainan Poly Pharm Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Oral Anti-allergic Drugs Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck Oral Anti-allergic Drugs Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Pfizer
  56. 7.10.1 Pfizer Company Information
  57. 7.10.2 Pfizer Business Overview
  58. 7.10.3 Pfizer Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Pfizer Oral Anti-allergic Drugs Product Portfolio
  60. 7.10.5 Pfizer Recent Developments
  61. 7.11 GlaxoSmithKline
  62. 7.11.1 GlaxoSmithKline Company Information
  63. 7.11.2 GlaxoSmithKline Business Overview
  64. 7.11.3 GlaxoSmithKline Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 GlaxoSmithKline Oral Anti-allergic Drugs Product Portfolio
  66. 7.11.5 GlaxoSmithKline Recent Developments
  67. 7.12 Dawnrays Pharma
  68. 7.12.1 Dawnrays Pharma Company Information
  69. 7.12.2 Dawnrays Pharma Business Overview
  70. 7.12.3 Dawnrays Pharma Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Dawnrays Pharma Oral Anti-allergic Drugs Product Portfolio
  72. 7.12.5 Dawnrays Pharma Recent Developments
  73. 7.13 Bayer
  74. 7.13.1 Bayer Company Information
  75. 7.13.2 Bayer Business Overview
  76. 7.13.3 Bayer Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bayer Oral Anti-allergic Drugs Product Portfolio
  78. 7.13.5 Bayer Recent Developments
  79. 7.14 AstraZeneca
  80. 7.14.1 AstraZeneca Company Information
  81. 7.14.2 AstraZeneca Business Overview
  82. 7.14.3 AstraZeneca Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 AstraZeneca Oral Anti-allergic Drugs Product Portfolio
  84. 7.14.5 AstraZeneca Recent Developments
  85. 7.15 UCB Pharma
  86. 7.15.1 UCB Pharma Company Information
  87. 7.15.2 UCB Pharma Business Overview
  88. 7.15.3 UCB Pharma Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 UCB Pharma Oral Anti-allergic Drugs Product Portfolio
  90. 7.15.5 UCB Pharma Recent Developments
  91. 7.16 Boehringer Ingelheim
  92. 7.16.1 Boehringer Ingelheim Company Information
  93. 7.16.2 Boehringer Ingelheim Business Overview
  94. 7.16.3 Boehringer Ingelheim Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Boehringer Ingelheim Oral Anti-allergic Drugs Product Portfolio
  96. 7.16.5 Boehringer Ingelheim Recent Developments
  97. 7.17 Almirall
  98. 7.17.1 Almirall Company Information
  99. 7.17.2 Almirall Business Overview
  100. 7.17.3 Almirall Oral Anti-allergic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Almirall Oral Anti-allergic Drugs Product Portfolio
  102. 7.17.5 Almirall Recent Developments
8 North America
  1. 8.1 North America Oral Anti-allergic Drugs Market Size by Type
  2. 8.1.1 North America Oral Anti-allergic Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Anti-allergic Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Anti-allergic Drugs Price by Type (2021-2032)
  5. 8.2 North America Oral Anti-allergic Drugs Market Size by Application
  6. 8.2.1 North America Oral Anti-allergic Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Anti-allergic Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Anti-allergic Drugs Price by Application (2021-2032)
  9. 8.3 North America Oral Anti-allergic Drugs Market Size by Country
  10. 8.3.1 North America Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Anti-allergic Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oral Anti-allergic Drugs Market Size by Type
  2. 9.1.1 Europe Oral Anti-allergic Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Anti-allergic Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Anti-allergic Drugs Price by Type (2021-2032)
  5. 9.2 Europe Oral Anti-allergic Drugs Market Size by Application
  6. 9.2.1 Europe Oral Anti-allergic Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Anti-allergic Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Anti-allergic Drugs Price by Application (2021-2032)
  9. 9.3 Europe Oral Anti-allergic Drugs Market Size by Country
  10. 9.3.1 Europe Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Anti-allergic Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oral Anti-allergic Drugs Market Size by Type
  2. 10.1.1 China Oral Anti-allergic Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Anti-allergic Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Oral Anti-allergic Drugs Price by Type (2021-2032)
  5. 10.2 China Oral Anti-allergic Drugs Market Size by Application
  6. 10.2.1 China Oral Anti-allergic Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Anti-allergic Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Oral Anti-allergic Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Anti-allergic Drugs Market Size by Type
  2. 11.1.1 Asia Oral Anti-allergic Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Anti-allergic Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Anti-allergic Drugs Price by Type (2021-2032)
  5. 11.2 Asia Oral Anti-allergic Drugs Market Size by Application
  6. 11.2.1 Asia Oral Anti-allergic Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Anti-allergic Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Anti-allergic Drugs Price by Application (2021-2032)
  9. 11.3 Asia Oral Anti-allergic Drugs Market Size by Country
  10. 11.3.1 Asia Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Anti-allergic Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Anti-allergic Drugs Market Size by Type
  2. 12.1.1 SAMEA Oral Anti-allergic Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Anti-allergic Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Anti-allergic Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Anti-allergic Drugs Market Size by Application
  6. 12.2.1 SAMEA Oral Anti-allergic Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Anti-allergic Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Anti-allergic Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Anti-allergic Drugs Market Size by Country
  10. 12.3.1 SAMEA Oral Anti-allergic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Anti-allergic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Anti-allergic Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Anti-allergic Drugs Value Chain Analysis
  2. 13.1.1 Oral Anti-allergic Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Anti-allergic Drugs Production Mode & Process
  6. 13.2 Oral Anti-allergic Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Anti-allergic Drugs Distributors
  9. 13.2.3 Oral Anti-allergic Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst